Autolus Therapeutics (AUTL) announced the appointment of Ryan Richardson to the Company’s Board of Directors. Richardson previously served as Chief Strategy Officer and member of the Management Board of BioNTech during his tenure from September 2018 to September 2025.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AUTL:
- Midday Fly By: Alphabet continues ascent, fueled by AI optimism
- Autolus Therapeutics announces NICE draft guidance recommending Aucatzyl
- Autolus Therapeutics Reports Q3 2025 Financial Results
- Autolus Therapeutics’ Earnings Call: Mixed Sentiments
- Autolus Therapeutics: Strong Buy Rating Backed by Growth Potential and Strategic Advancements